Ontology highlight
ABSTRACT:
SUBMITTER: Pezzicoli G
PROVIDER: S-EPMC8500499 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Pezzicoli Gaetano G Filoni Elisabetta E Gernone Angela A Cosmai Laura L Rizzo Mimma M Porta Camillo C
Cancer management and research 20211004
In the last decade, the inhibition of the mechanistic target of Rapamycin (mTOR) in renal clear cell carcinoma (RCC) has disappointed the clinician's expectations. Many clinical trials highlighted the low efficacy and unmanageable safety profile of first-generation mTOR inhibitors (Rapalogs), thus limiting their use in the clinical practice only to those patients who already failed several therapy lines. In this review, we analyze the major resistance mechanisms that undermine the efficacy of th ...[more]